StageSeries A | Alive
Last Raised$55M | 10 mos ago
About ForSight Robotics
ForSight Robotics develops a surgical robotic platform to deliver high precision, cost-effective, vision-saving surgery. ForSight Robotics was founded in 2020 and is based in Yokne’am Illit, Israel.
Missing: ForSight Robotics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ForSight Robotics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing ForSight Robotics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ForSight Robotics is included in 4 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
ForSight Robotics Patents
ForSight Robotics has filed 2 patents.
The 3 most popular patent topics include:
- Aircraft instruments
- Diseases of the eye and adnexa
Latest ForSight Robotics News
May 10, 2023
Source: Thompson V. Refractive cataract surgery: Under pressure. Disclosures: Thompson reports having financial disclosures for 2EyesVision, AcuFocus, AdOM, AI Optics, Alcon, Allergan, Allotex, Avellino, Avisi Technologies, Bausch + Lomb, Brim Biotechnology, BVI, Carl Zeiss Meditec, Centricity, Conjtac, Crystilex, CSO, D&D Biopharmaceuticals, Equinox, Euclid Systems, Expert Opinion, eyeBrain Medical, Eyedetec, Eyesafe, Fontana Biosciences, Forsight Robotics, Glaukos, Imprimis, iVeena, Johnson & Johnson, LayerBio, LifeLong Vision, Medevise, Melt Pharmaceuticals, Ocular Innovations, Ocular Therapeutix, Oyster Point Pharma, Rayner, Reopia, RxSight, Sight Sciences, Singular Strategies, Stepwise Medical, Stuart Therapeutics, Tarsus Rx, TearClear, TearOptix, Thea, TherOptix, Treehouse Health, Vance Thompson Vision, Visant, Visionary Ventures, Visus and Vivior. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact email@example.com . Back to Healio The path to better vision may take 1 year. SAN DIEGO — Surgeons should optimize their treatment of dysphotopsias based on each patient’s natural ability for neuroadaptation , according to a speaker here. According to Vance Thompson, MD, who gave the Steinert Lecture at Refractive Day at the American Society of Cataract and Refractive Surgery meeting, it is important to help patients overcome “the combination of glare, halo and starburst. We have to minimize what we can help with and reduce it to a halo so that they can now neuroadapt.” According to Thompson, every patient has a varying ability for neuroadaptation to dysphotopsias, meaning there is a way for surgeons to optimize their treatment approach for each patient. “So, how we optimize is we just work our way back in the eye and start knocking out every source of glare until we get to that source of glare,” he said. To optimize treatment, it is important to understand the distinct relationship between P1 and P4 Purkinje light reflections when performing capsulotomy. “If you know the relationship of P1 and P4 with fixation, you can just reestablish [fixation] manually,” he said. “Those two images in surgery are always there for you to use.” Overall, Thompson said that it is important to reassure patients that the path to better vision outcomes will most likely be a “1-year journey,” with the first 6 months focusing on healing and optimizing image quality and the second 6 months being when the patient’s brain eliminates or minimizes lingering halo through neuroadaptation. “If you can think about this as a 1-year journey, you are going to be happy,” Thompson said. Read more about
ForSight Robotics Frequently Asked Questions (FAQ)
When was ForSight Robotics founded?
ForSight Robotics was founded in 2020.
Where is ForSight Robotics's headquarters?
ForSight Robotics's headquarters is located at 1 Ha’Tzmicha street, Yokne'am Illit.
What is ForSight Robotics's latest funding round?
ForSight Robotics's latest funding round is Series A.
How much did ForSight Robotics raise?
ForSight Robotics raised a total of $65M.
Who are the investors of ForSight Robotics?
Investors of ForSight Robotics include Mithril Capital Management, Eclipse Ventures, Ljungstrom Family Office, Precision Capital, Adani Group and 4 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.